Pharma BD Deal Intelligence
Novartis AG / The Medicines Company
2002 · Acquisition/Merger · $9.7B · Complete
Announcement Sentiment
38
Skeptical
Outcome Score
67
Largely worked — most objectives met.
Novartis acquired The Medicines Company for $9.7B for inclisiran cholesterol therapy.
Key facts
- Announced Dec 18, 2002
- Closed Jan 06, 2020
- Deal value $9.7B
- Deal type Acquisition/Merger
- Therapeutic area Cardiovascular
- Key assets inclisiran
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals